학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 7,866건 | 목록 1~20
Commentary on “Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.” Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Røder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC; COGS–Cancer Research UK GWAS–ELLIPSE (part of GAME-ON) Initiative; Australian Prostate Cancer Bioresource; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT (Prostate testing for cancer and Treatment) Study Collaborators; PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Kote-Jarai Z, Easton DF, The Institute of Cancer Research, Sutton, UK.: Nat Genet 2013;45(5):385–91, 391e1–2
Academic Journal
In Urologic Oncology: Seminars and Original Investigations February 2014 32(2):211-211
Regression of metastatic renal-cell carcinoma after nonmyeloablative peripheral-blood stem-cell transplantation. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S, Read EJ, Tisdale J, Dunbar C, Linehan WM, Young NS, Barrett AJ, Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892-1652, USA.childsr@nih.govProspective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer. Small EJ, Frohlich MW, Bok R, Shinohara K, Grossfeld G, Rozenblat Z, Kelly WK, Corry M, Reese DM, University of California at San Francisco, San Francisco, CA.Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. von der Maase H, Hansen SW, Roberts JT, Dogliotti L, Oliver T, Moore MJ, Bodrogi I, Albers P, Knuth A, Lippert CM, Kerbrat P, Sanchez Rovira P, Wersall P, Cleall SP, Roychowdhury DF, Tomlin I, Visseren-Grul CM, Conte PF, Aarhus University Hospital, Aarhus, Denmark.hvdm@oncology.dkImmediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. Messing EM, Manola J, Sarosdy M, Wilding G, Crawford ED, Trump D, University of Rochester Medical Center, Rochester, NY, USA.edwardvmessing@urmc.rochester.eduHealth outcomes after prostatectomy or radiotherapy for prostate cancer results from the prostate cancer outcomes study. Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, Eley JW, Stephenson RA, Harlan LC, Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA
Academic Journal
Urologic Oncology. 6:125-127
Academic Journal
UKGPCS collaborators 2021, 'Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer', Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-020-00311-2
Karunamuni, R, Walsh, E I, Turner, E L, Lane, J A, Martin, R M, Donovan, J L, Seibert, T M & et al. 2021, 'Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer', Prostate Cancer & Prostatic Diseases, vol. 24, no. 2, pp. 532-541. https://doi.org/10.1038/s41391-020-00311-2
UKGPCS Collaborators, APCB BioResource (Australian Prostate Cancer BioResource), IMPACT Study Steering Committee and Collaborators, Canary PASS Investigators, Profile Study Steering Committee & PRACTICAL consortium 2021, ' Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer ', Prostate Cancer and Prostatic Diseases, vol. 24, no. 2, pp. 532-541 . https://doi.org/10.1038/s41391-020-00311-2
UKGPCS Collaborators 2021, 'Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer', Prostate Cancer and Prostatic Diseases. https://doi.org/10.1038/s41391-020-00311-2
Prostate Cancer and Prostatic Diseases, vol 24, iss 2
Karunamuni, R A, Huynh-Le, M-P, Fan, C C, Thompson, W, Eeles, R A, Kote-Jarai, Z, Muir, K, Lophatananon, A, Schleutker, J, Pashayan, N, Batra, J, Grönberg, H, Walsh, E I, Turner, E L, Lane, A, Martin, R M, Neal, D E, Donovan, J L, Hamdy, F C, Nordestgaard, B G, Tangen, C M, MacInnis, R J, Wolk, A, Albanes, D, Haiman, C A, Travis, R C, Stanford, J L, Mucci, L A, West, C M L, Nielsen, S F, Kibel, A S, Wiklund, F, Cussenot, O, Berndt, S I, Koutros, S, Sørensen, K D, Cybulski, C, Grindedal, E M, Park, J Y, Ingles, S A, Maier, C, Hamilton, R J, Rosenstein, B S, Vega, A, Kogevinas, M, Penney, K L, Teixeira, M R, Brenner, H, John, E M, Kaneva, R & UKGPCS collaborators 2021, 'Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer', Prostate Cancer and Prostatic Diseases, vol. 24, pp. 532-541. https://doi.org/10.1038/s41391-020-00311-2
Academic Journal
Chen F; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Sheng X; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Wang A; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.; Xu Y; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Hughley R; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Xiong W; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Pooler L; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Wan P; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Gundell SM; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Kigozi G; Africa Medical and Behavioural Sciences Organization, Wakiso, Uganda.; Nakigozi G; Africa Medical and Behavioural Sciences Organization, Wakiso, Uganda.; Nalugoda F; Africa Medical and Behavioural Sciences Organization, Wakiso, Uganda.; Kagaayi J; Africa Medical and Behavioural Sciences Organization, Wakiso, Uganda.; Kigozi GN; Africa Medical and Behavioural Sciences Organization, Wakiso, Uganda.; Mugamba S; Africa Medical and Behavioural Sciences Organization, Wakiso, Uganda.; Kyasanku E; Africa Medical and Behavioural Sciences Organization, Wakiso, Uganda.; Nkale J; Africa Medical and Behavioural Sciences Organization, Wakiso, Uganda.; Olwa VO; Africa Medical and Behavioural Sciences Organization, Wakiso, Uganda.; Lubwama A; Africa Medical and Behavioural Sciences Organization, Wakiso, Uganda.; Daama A; Africa Medical and Behavioural Sciences Organization, Wakiso, Uganda.; Nakajugo R; Africa Medical and Behavioural Sciences Organization, Wakiso, Uganda.; Adusei B; 37 Military Hospital, Accra, Ghana.; Jalloh M; Department of Urology, University Cheikh Anta Diop de Dakar, Dakar, Senegal.; Gueye SM; Hôpital Général de Grand Yoff, Dakar, Senegal.; Adjei AA; Department of Pathology, University of Ghana Medical School College of Health Sciences Korle Bu Accra Ghana, Accra, Ghana.; Mensah J; Department of surgery, Division of Urology, Korle-Bu Hospital, Accra, Ghana.; Fernandez PW; Division of Urology, Stellenbosch University, Cape Town, South Africa.; Adebiyi AO; University College Hospital, Ibadan, Nigeria.; Olufemi Ogunbiyi J; Department of Pathology, College of Medicine, University of Ibadan, Ibadan, Nigeria.; Aisuodionoe-Shadrach OI; College of Health Sciences, University of Abuja & University of Abuja Teaching Hospital, Abuja, Nigeria; Cancer Science Centre, Abuja, Nigeria.; Petersen L; Mediclinic Precise, Cape Town, South Africa.; Chen WC; Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; National Cancer Registry, a Division of the National Institute for Communicable Diseases, National Health Laboratory Service, South Africa.; McBride J; Center for Proteomic & Genomic Research, Cape Town, South Africa.; Bensen JT; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Mohler JL; Department of Urology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.; Taylor JA; Epidemiology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.; Andrews C; Medical Oncology, Population Sciences, Dana Farber Cancer Institute, Boston, MA, USA.; Kigongo M; Uro Care Hospital, Kampala, Uganda.; Colline A; Uro Care Hospital, Kampala, Uganda.; Kiddu V; Uro Care Hospital, Kampala, Uganda.; Namugambe J; Uro Care Hospital, Kampala, Uganda.; Owamaani S; Nikao Medical Center, Kampala, Uganda.; Job K; Mulago Hospital, Nikao Medical Center, Kampala, Uganda.; Masaba BJ; Mulago Hospital, Kampala, Uganda.; Asiimwe F; Mulago Hospital, Kampala, Uganda.; Muwanga P; Mulago Hospital, Kampala, Uganda.; Namulondo J; Mulago Hospital, Kampala, Uganda.; Nagawa F; Mulago Hospital, Kampala, Uganda.; Kayiraba C; Mulago Hospital, Kampala, Uganda.; Ogwang M; Lacor Hospital, Gulu, Uganda.; Okidi R; Lacor Hospital, Gulu, Uganda.; Oweka D; Lacor Hospital, Gulu, Uganda.; Kitara E; Lacor Hospital, Gulu, Uganda.; Obonyo J; Lacor Hospital, Gulu, Uganda.; Lajul D; Lacor Hospital, Gulu, Uganda.; Matovu P; Kisiizi Hospital, Rukungiri, Uganda.; Muheki PA; Kisiizi Hospital, Rukungiri, Uganda.; Natumanya J; Kisiizi Hospital, Rukungiri, Uganda.; Agaba E; Kisiizi Hospital, Rukungiri, Uganda.; Aculokin E; Kisiizi Hospital, Rukungiri, Uganda.; Twongyeirwe A; Kisiizi Hospital, Rukungiri, Uganda.; Mutema G; Surgipath, Kampala, Uganda.; Bitamazire D; Hoima Regional Referral Hospital, Hoima, Uganda.; Butler EN; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Ingles SA; Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Rybicki BA; Department of Public Health Sciences, Henry Ford Hospital, Detroit, MI, USA.; Stanford JL; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Zheng W; Division of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.; Berndt SI; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.; Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.; Huff CD; Department of Epidemiology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.; Lachance J; School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA.; Multigner L; Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail), Rennes, France.; Darst BF; Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Rebbeck TR; Harvard TH Chan School of Public Health and Division of Population Sciences, Dana Farber Cancer Institute, Boston, MA, USA.; Brureau L; CHU de Pointe-à-Pitre, Univ Antilles, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail), Pointe-à-Pitre, Guadeloupe, France.; Watya S; Uro Care Hospital, Kampala, Uganda; Africa Medical and Behavioural Sciences Organization (AMBSO), Wakiso, Uganda.; Conti DV; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Haiman CA; Center for Genetic Epidemiology, Department of Population and Public Health Sciences, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Electronic address: haiman@usc.edu.
Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Academic Journal
Schumacher, FROlama, AABerndt, SIBenlloch, SAhmed, MSaunders, EJDadaev, TLeongamornlert, DAnokian, ECieza-Borrella, CGoh, CBrook, MNSheng, XFachal, LDennis, JTyrer, JMuir, KLophatananon, AStevens, VLGapstur, SMCarter, BDTangen, CMGoodman, PJThompson, IMBatra, JChambers, SMoya, LClements, JHorvath, LTilley, WRisbridger, GPGronberg, HAly, MNordström, TPharoah, PPashayan, NSchleutker, JTammela, TLJSipeky, CAuvinen, AAlbanes, DWeinstein, SWolk, AHåkansson, NWest, CMLDunning, AMBurnet, NMucci, LAGiovannucci, EAndriole, GLCussenot, OCancel-Tassin, GKoutros, SFreeman, LE BeaneSorensen, KDOrntoft, TFBorre, MMaehle, LGrindedal, EMNeal, DEDonovan, JLHamdy, FCMartin, RMTravis, RCKey, TJHamilton, RJFleshner, NEFinelli, AIngles, SAStern, MCRosenstein, BSKerns, SLOstrer, HLu, Y-JZhang, H-WFeng, NMao, XGuo, XWang, GSun, ZGiles, GGSouthey, MCMacinnis, RJFitzgerald, LMKibel, ASDrake, BFVega, AGómez-Caamaño, ASzulkin, REklund, MKogevinas, MLlorca, JCastaño-Vinyals, GPenney, KLStampfer, MPark, JYSellers, TALin, H-YStanford, JLCybulski, CWokolorczyk, DLubinski, JOstrander, EAGeybels, MSNordestgaard, BGNielsen, SFWeischer, MBisbjerg, RRøder, MAIversen, PBrenner, HCuk, KHolleczek, BMaier, CLuedeke, MSchnoeller, TKim, JLogothetis, CJJohn, EMTeixeira, MRPaulo, PCardoso, MNeuhausen, SLSteele, LDing, YCDe Ruyck, KDe Meerleer, GOst, PRazack, ALim, JTeo, S-HLin, DWNewcomb, LFLessel, DGamulin, MKulis, TKaneva, RUsmani, NSinghal, SSlavov, CMitev, VParliament, MClaessens, FJoniau, SVan Den Broeck, TLarkin, STownsend, PAAukim-Hastie, CGago-Dominguez, MCastelao, JEMartinez, MERoobol, MJJenster, GVan Schaik, RHNMenegaux, FTruong, TKoudou, YAXu, JKhaw, K-TCannon-Albright, LPandha, HMichael, AThibodeau, SNMcDonnell, SKSchaid, DJLindstrom, STurman, CMa, JHunter, DJRiboli, ESiddiq, ACanzian, FKolonel, LNLe Marchand, LHoover, RNMachiela, MJCui, ZKraft, PAmos, CIConti, DVEaston, DFWiklund, FChanock, SJHenderson, BEKote-Jarai, ZHaiman, CAEeles, RAStudy, ProfileBioresource, AStudy, ImpactInvestigators, Canary Pass(Bpc3), Breast And Prostate Cancer Cohort ConsortiumConsortium, Practical (Prostate Cancer Association Group To Investigate Cancer-Associated Alterations In The Genome)Sweden, C(Pegasus), Prostate Cancer Genome-Wide Association Study Of Uncommon Susceptibility LociConsortium, Genetic Associations And Mechanisms In Oncology (Game-On)/Elucidating Loci Involved In Prostate Cancer Susceptibility (Ellipse)
the Profile Study 2018, 'Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci', Nature Genetics, vol. 50, no. 7, 8, pp. 928-936. https://doi.org/10.1038/s41588-018-0142-8
Muir, K, Lophatananon, A, West, C, Townsend, P, Burnet, N & et al. 2018, 'Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci.', Nat Genet, vol. 50, no. 7, pp. 928-936. https://doi.org/10.1038/s41588-018-0142-8
Nature Genetics, vol 50, iss 7
Schumacher, F R, Al Olama, A A, Berndt, S I, Benlloch, S, Ahmed, M, Saunders, E J, Dadaev, T, Leongamornlert, D, Anokian, E, Cieza-Borrella, C, Goh, C, Brook, M N, Sheng, X, Fachal, L, Dennis, J, Tyrer, J, Muir, K, Lophatananon, A, Stevens, V L, Gapstur, S M, Carter, B D, Tangen, C M, Goodman, P J, Thompson, I M, Batra, J, Chambers, S, Moya, L, Clements, J, Horvath, L, Tilley, W, Risbridger, G P, Gronberg, H, Aly, M, Nordström, T, Pharoah, P, Pashayan, N, Schleutker, J, Tammela, T L J, Sipeky, C, Auvinen, A, Albanes, D, Weinstein, S, Wolk, A, Sorensen, K D, Orntoft, T F, Borre, M & Profile Study 2018, 'Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci', Nature Genetics, vol. 50, no. 7, pp. 928-936. https://doi.org/10.1038/s41588-018-0142-8
Academic Journal
Int J Cancer
Bonilla, C, Lewis, S, Rowlands, M-A, Gaunt, T, Davey Smith, G, Gunnell, D, Palmer, T, Donovan, J, Hamdy, F C, Neal, D E, Eeles, R, Easton, D, Kote-Jarai, Z, Al Olama, A A, Benlloch, S, Muir, K, Giles, G G, Wiklund, F, Gronberg, H, Haiman, C A, Schleutker, J, Nordestgaard, B G, Travis, R C, Pashayan, N, Khaw, K-T, Stanford, J L, Blot, W J, Thibodeau, S, Maier, C, Kibel, A S, Cybulski, C, Cannon-Albright, L, Brenner, H, Park, J, Kaneva, R, Batra, J, Teixeira, M R, Pandha, H, The PRACTICAL, C, Lathrop, M, Martin, R & Holly, J 2016, 'Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization : genetic variants as instruments for circulating levels.', International Journal of Cancer, vol. 139, no. 7, pp. 1520-1533. https://doi.org/10.1002/ijc.30206
Bonilla, C, Lewis, S J, Rowlands, M-A, Gaunt, T R, Davey-Smith, G, Gunnell, D, Palmer, T M, Donovan, J L, Hamdy, F C, Neal, D E, Eeles, R, Easton, D, Kote-Jarai, Z, Al Olama, A A, Benlloch, S, Muir, K, Giles, G, Wiklund, F, Grönberg, H, Haiman, C A, Schleutker, J, Nordestgaard, B G, Travis, R C, Pashayan, N, Khaw, K-T, Stanford, J L, Blot, W J, Thibodeau, S N, Maier, C, Kibel, A S, Cybulski, C, Cannon-Albright, L, Brenner, H, Park, J-S, Kaneva, R, Batra, J, Teixeira, M R, Pandha, H, PRACTICAL consortium, Lathrop, M, Martin, R M & Holly, J M P 2016, ' Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization : Genetic variants as instruments for circulating levels ', International Journal of Cancer, vol. 139, no. 7, pp. 1520-1533 . https://doi.org/10.1002/ijc.30206
Bonilla, C, Lewis, S J, Rowlands, M A, Gaunt, T R, Davey Smith, G, Gunnell, D, Palmer, T, Donovan, J L, Hamdy, F C, Neal, D E, Eeles, R, Easton, D, Kote-Jarai, Z, Al Olama, A A, Benlloch, S, Muir, K, Giles, G G, Wiklund, F, Grönberg, H, Haiman, C A, Schleutker, J, Nordestgaard, B G, Travis, R C, Pashayan, N, Khaw, K T, Stanford, J L, Blot, W J, Thibodeau, S, Maier, C, Kibel, A S, Cybulski, C, Cannon-Albright, L, Brenner, H, Park, J, Kaneva, R, Batra, J, Teixeira, M R, Pandha, H, Lathrop, M, Martin, R M & Holly, J M P 2016, 'Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization : Genetic variants as instruments for circulating levels', International Journal of Cancer, vol. 139, no. 7, pp. 1520-1533. https://doi.org/10.1002/ijc.30206
Academic Journal
Adams, C, Richmond, R C, Santos Ferreira, D L D, Spiller, W, Tan, V Y, Zheng, J, Wurtz, P, Donovan, J L, Hamdy, F C, Neal, D E, Lane, J A, Davey Smith, G, Relton, C L, Eeles, R A, Henderson, B E, Haiman, C A, Kote-Jarai, Z, Schumacher, F R, Amin Al Olama, A, Benlloch, S, Muir, K, Berndt, S I, Conti, D V, Wiklund, F, Chanock, S J, Gapstur, S M, Stevens, V L, Tangen, C M, Batra, J, Clements, J A, Grönberg, H, Pashayan, N, Schleutker, J, Albanes, D, Wolk, A, West, C M L, Mucci, L A, Cancel-Tassin, G, Koutros, S, Sørensen, K D, Maehle, L, Travis, R C, Hamilton, R, Ingles, S A, Rosenstein, B S, Lu, Y-J, Giles, G G, Kibel, A S, Vega, A, Kogevinas, M, Penney, K L, Park, J Y, Stanford, J L, Cybulski, C, Nordestgaard, B G, Brenner, H, Maier, C, Kim, J, John, E M, Teixeira, M R, Neuhausen, S L, DeRuyck, K, Razack, A, Newcomb, L F, Lessel, D, Kaneva, R P, Usmani, N, Claessens, F, Townsend, P, Gago Dominguez, M, Roobol, M J, Menegaux, F, Khaw, K-T, Cannon-Albright, L A, Pandha, H, Thibodeau, S N & Martin, R M 2019, 'Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study', Cancer Epidemiology, Biomarkers and Prevention, vol. 28, no. 1, pp. 208-216. https://doi.org/10.1158/1055-9965.EPI-18-0079
PRACTICAL Consortium 2019, 'Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study', Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol. 28, no. 1, pp. 208-216. https://doi.org/10.1158/1055-9965.EPI-18-0079
Adams, C D, Richmond, R, Ferreira, D L S, Spiller, W, Tan, V, Zheng, J, Würtz, P, Donovan, J, Hamdy, F, Neal, D, Lane, J A, Smith, G D, Relton, C, Eeles, R A, Haiman, C A, Kote-Jarai, ZS, Schumacher, F R, Olama, A A A, Benlloch, S, Muir, K, Berndt, S I, Conti, D V, Wiklund, F, Chanock, S J, Gapstur, S, Stevens, V L, Tangen, C M, Batra, J, Clements, J A, Gronberg, H, Pashayan, N, Schleutker, J, Albanes, D, Wolk, A, West, C M L, Mucci, L A, Cancel-Tassin, G, Koutros, S, Sorensen, K D, Maehle, L, Travis, R C, Hamilton, R J, Ingles, S A, Rosenstein, B S, Lu, Y-J, Giles, G G, Kibel, A S, Vega, A, Kogevinas, M, Penney, K L, The PRACTICAL Consortium, Martin, R M & Nordestgaard, B G 2019, 'Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study', Cancer Epidemiology, Biomarkers & Prevention, vol. 28, no. 1, pp. 208-216. https://doi.org/10.1158/1055-9965.EPI-18-0079
검색 결과 제한하기
제한된 항목
[검색어] Stanford, JL
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어